Gene Name |
exocyst complex component 8 |
v-ral simian leukemia viral oncogene homolog A (ras related) |
Image |
No pdb structure |
|
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
|
Protein-Protein Interactions |
20 interactors:
BLOC1S6
CCDC85B
CEP57L1
EFHC2
EXOC2
HGS
IKZF3
KRT15
KRT18
KRT19
KRT20
KRT31
LNX1
MBIP
PCM1
RAB3IL1
RALA
TADA2A
ULK1
USHBP1
|
32 interactors:
ARF1
CALM1
CNKSR2
EXOC1
EXOC2
EXOC3
EXOC4
EXOC5
EXOC6B
EXOC7
EXOC8
FLNA
HRAS
LRPAP1
LSM2
PIH1D2
PLCD1
PLD1
PPP2R1B
RAB34
RAB8B
RALBP1
RALGPS1
RAP1A
RAP2A
RAP2B
RASSF5
REPS1
RGL2
RGL4
SMAD4
YBX3
|
Entrez ID |
149371 |
5898 |
HPRD ID |
09943 |
01549 |
Ensembl ID |
ENSG00000116903
|
ENSG00000006451
|
Uniprot IDs |
Q8IYI6
|
P11233
|
PDB IDs |
|
1UAD
1ZC3
1ZC4
2A78
2A9K
2BOV
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
adoptive
antitumor
capability
chimeric
combining
effectors
engineered
fused
genetically
gtp
immunotherapeutic
killer
meaningful
mhc
moieties
ncr1
ncrs
nk
nkp46
partly
proto
ralb
recognition
recognize
regressions
remarkable
retrovirally
termed
|
Tagcloud (Difference) ? |
|
adoptive
antitumor
capability
chimeric
combining
effectors
engineered
fused
genetically
gtp
immunotherapeutic
killer
meaningful
mhc
moieties
ncr1
ncrs
nk
nkp46
partly
proto
ralb
recognition
recognize
regressions
remarkable
retrovirally
termed
|
Tagcloud (Intersection) ? |
|